Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Clinical trial NCT07257471 · RECRUITING

Trial details

NCT number: NCT07257471
Sponsor: Beijing Haidian Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer (NSCLC)

Start date: 2025-06-06
Primary completion: 2028-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.